Clinical Trial Update: Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating temozolomide in previously untreated acute myeloid leukemia and myelodysplastic syndrome patients with low MGMT expression; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Leukemia, Acute Myeloid, Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2012-07-18